Raffles Medical Group
Raffles Medical Group is a private healthcare provider in Asia, operating medical facilities in thirteen cities in Singapore, China, Japan, Vietnam and Cambodia.
See below for the Latest Raffles Medical Group News, Analysis, Profit Results, Share Price Information, and Commentary.
Raffles Medical Group’s profit drops 48.8% YoY to $30.6m in H1
Revenue slipped 1.4% to $365.7m in the same period.
Raffles Medical Group’s profit drops 48.8% YoY to $30.6m in H1
Revenue slipped 1.4% to $365.7m in the same period.
Raffles Medical chairman acquires 800,000 shares, raising stake
His latest purchase increased his stake to 54%.
Raffles Medical chairman increases stake with 900,000 share purchase
Loo Choon Yong acquired the new shares for $1.02 apiece.
Raffles Medical Group’s PATMI drops 37.1% YoY to $90.2m in FY23
The company attributed the decline to the discontinuance of its COVID-related activities.
Raffles Medical Group’s profit falls 67.4% YoY top $12.4m in 3Q23
Year-to-date, the company’s profit has declined 25.6% YoY.
Raffles Medical Group’s PATMI rises slightly by 0.5% YoY to $59.9m in 1H23
Its revenue, however, fell by 9.5% YoY.
Raffles Medical’s profit after tax soars 71.7% YoY to $143.7m in FY22
The company attributed the increase to the return of foreign patients.
Raffles Medical Group to get higher margins amidst China reopening
Elective surgery revival will benefit the hospital group.
After mitigating cost pressures, Raffles Medical records 62.1% net profit growth
One of the biggest medical groups posted a net profit of $38.3m.
Raffles Medical Group to get positive contribution from China operations: analyst
Its target price was at $1.60.
Raffles Medical H1 profit surges 54.4%
Patient numbers had increased on the back of recovering medical tourism.
Raffles Medical Group to see a 10% decline in H122 net profit: forecast
This is on the back of expected lower revenue from the hospital's COVID-19 services.
Raffles Medical Group earnings per share estimate cut by 8-12% for FY22/24
Maybank Securities Research cited two reasons for its lower estimate.
Raffles Medical Group’s H2 2021 net profit declines 7.2% to $44.88m
This is despite a 16.3% increase in its revenue during the same period.
STI to reach 3,500 in 2022: UOB Kay Hian
The bullish forecast is attributed to the strong GDP growth in 2021.
Raffles Medical set to profit from the opening of SIngapore’s borders - RHB
The company is the sole provider of Covid-19 PCR tests for Changi Airport.
Read Here
Advertise
Sign Up
